American Airlines heads into October earnings with short interest climbing sharply, analysts cutting targets across the board, and the stock down 14% over the past month to $12.77 — a setup that tells a consistent story of mounting skepticism.
The most striking development this week is the pace at which short sellers have added to their positions. Short interest has risen 11.5% over the past week to 12.2% of the free float — about 80.7 million shares — and is up more than 26% over the past month. That monthly build is one of the more aggressive accumulation runs in recent memory for a large-cap airline. The direction of travel has been unambiguous: from roughly 55.6 million shares short in mid-August to over 80 million today, bears have steadily pressed their case as the stock fell. Despite that build, the borrow market remains surprisingly relaxed. Availability is running at 547%, meaning there are still more than five shares available for every two already borrowed — plenty of room for further short expansion without any squeeze pressure. Cost to borrow has ticked up 32% on the week to 0.46%, but remains essentially negligible. Borrowing AAL is cheap and easy. The options market reinforces the cautious tone but without any extreme signal: the put/call ratio is 1.54, essentially in line with its 20-day average of 1.54 and nowhere near the 52-week high of 2.41, suggesting hedging demand is elevated but not panicked.
The Street is sending the same message as the short sellers, just more politely. Barclays cut its price target from $19 to $14 this week while holding an Equal-Weight rating — a rare instance of a target dropping almost to the current price. UBS trimmed from $18 to $17 while keeping a Buy, and TD Cowen made the most dramatic move in August, slashing its target from $24 to $16. JP Morgan stands out as the lone contrarian, raising its target from $22 to $24 with an Overweight rating after the most recent earnings. Goldman Sachs maintains a Sell with a $13 target — effectively flagging further downside from here. The mean analyst target of $17.85 implies around 40% upside from the current price, but that figure is being pulled higher by a handful of optimistic holdouts; the direction of travel on targets is uniformly downward. Factor scores add nuance: the 90-day EPS momentum rank is exceptional at the 98th percentile, and the EPS surprise rank is in the 95th, suggesting the company has been beating lowered estimates. But the 30-day EPS momentum has collapsed to the 16th percentile, indicating near-term analyst estimate revisions have turned negative again.
The institutional picture shows some meaningful positioning changes worth noting. PRIMECAP Management, the largest holder at 10.7% of shares, added roughly 21.7 million shares in the quarter through June — a substantial conviction bet by a long-only manager not known for momentum trading. Two Sigma added 13.1 million shares and Orbis 13.9 million over the same period. These are significant inflows. On the insider side, the recent activity is one-directional and notable: Vice Chair Stephen Johnson sold 150,000 shares across four days in late July at prices around $15, while SVP Corporate Controller Angela Owens sold nearly 80,000 shares over the same stretch. None of these sales were conducted under a 10b5-1 plan, making them discretionary transactions. Insiders were selling at $15 — 17% above where the stock trades today.
Earnings are due October 21. The two most recent prints offer a split picture: last July's result sent the stock down 2% on the day before recovering 4% over the following week, while the prior quarter's print triggered an 11% single-day drop. With short interest now more than double what it was entering that weaker print, and analysts still trimming targets, the October release takes on added weight. DAL fell just 0.1% on the week and UAL slipped 1.2%, suggesting AAL's 1.1% weekly decline reflects company-specific pressure rather than a broad sector move. The gap between AAL and its large network peers has been widening, and the next earnings call — covering the key back-to-school and early fall travel window — will be the moment the market tests whether that gap is justified.
See the live data behind this article on ORTEX.
Open AAL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
